 - Participation in an investigational drug trial including studies investigating VX-661ivacaftor or lumacaftorivacaftor other than the parent studies of NCT02565914 or other eligible Vertex studies investigating VX-661 in combination with ivacaftor, or use of a commercially available CFTR modulator. 